Publisher
Springer Science and Business Media LLC
Subject
General Biochemistry, Genetics and Molecular Biology,General Medicine
Reference99 articles.
1. Rogers AP, Estes M. Hyperviscosity syndrome. StatPearls[internet]; 2021Jul21.
2. Owen RG, McCarthy H, Rule S, d’Sa S, et al. Acalabrutinib monotherapy in patients with Waldenströmmacroglobulinemia: a single-arm, multicentre, phase 2 study. Lancet Haematol. 2020;7(2):e112–21. https://doi.org/10.1016/S2352-3026(19)30210-8.
3. Stone MJ, Bogen SA. Evidence-based focused review of management of hyperviscosity syndrome. Blood. 2012;119(10):2205–8. https://doi.org/10.1182/blood-2011-04-347690.
4. Bekelman J, Jackson N, Donehower R. Oncologic emergencies. 2nd ed. Philadelphia: Saunders Elsevier; 2006.
5. Joob B, Wiwanitkit V. Expected viscosityafter COVID-19 vaccination, hyperviscosity and previous COVID-19. Clin ApplThromb Hemost. 2021. https://doi.org/10.1177/10760296211020833.
Cited by
18 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献